PMID: 7174861Dec 1, 1982Paper

The classification of anxiety and hysterical states. Part II. Toward a more heuristic classification

Journal of Clinical Psychopharmacology
D V Sheehan, K H Sheehan

Abstract

In the historical review and empirical delineation of the classification of anxiety and hysterical states (Part I), it was concluded that the existing classifications are unsatisfactory and require some reconceptualization if they are to be useful clinically and empirically. In keeping with more recent developments in the genetic, behavioral, pharmacological, biochemical, and psychophysiological investigation of these disorders, a new classification is proposed. The two major categories of anxiety and hysterical disorders have a different clinical presentation and course, a different mean age of onset, distribution of age of onset, sex distribution, response to treatment modalities, and habituation response on galvanic skin response. Empirical evidence supporting this proposal is cited. This classification has heuristic merit in guiding research efforts and discussions and in directing clinicians to a simple and practical solution to their patients' anxiety disorders.

Citations

Nov 1, 1990·Social Psychiatry and Psychiatric Epidemiology·J H BoydD A Regier
Nov 1, 1989·Social Psychiatry and Psychiatric Epidemiology·J P LepineJ Lellouch
Jan 1, 1993·Journal of Psychiatric Research·A FrancesW W Davis
Sep 1, 1987·Journal of Affective Disorders·D V Sheehan
Aug 1, 1983·Psychiatry Research·J I HudsonD Yurgelun-Todd
May 1, 1987·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·M S KoppI Bitter
Mar 1, 1989·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·M Kopp, J Gruzelier
Jan 1, 1983·Progress in Neuro-psychopharmacology & Biological Psychiatry·D V Sheehan
Jan 1, 1983·Progress in Neuro-psychopharmacology & Biological Psychiatry·Y D Lapierre
Jan 1, 1987·Progress in Neuro-psychopharmacology & Biological Psychiatry·R P SwinsonK Kuch
Jan 1, 1988·Progress in Neuro-psychopharmacology & Biological Psychiatry·V J Knott, Y D Lapierre
Jan 1, 1990·Progress in Neuro-psychopharmacology & Biological Psychiatry·J C Pecknold, L Luthe
Feb 20, 2004·Journal of Behavior Therapy and Experimental Psychiatry·H SwobodaM Amering
Nov 25, 1996·Journal of Affective Disorders·G Scheibe, M Albus
Mar 5, 2003·Journal of Anxiety Disorders·Hemma SwobodaH Katschnig
Jan 1, 1997·European Psychiatry : the Journal of the Association of European Psychiatrists·G LangsH Zapotoczky
Sep 1, 1986·The Australian and New Zealand Journal of Psychiatry·F K Judd, G D Burrows
Mar 1, 1989·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·M S KoppK Buza
May 1, 1986·Psychosomatics·C V Ford
May 4, 2010·L'Encéphale·O AmamiL Aribi
Jan 1, 1989·Behaviour Research and Therapy·C de RuiterF Kraaimaat
Jul 1, 1985·Special Care in Dentistry : Official Publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry·A A Weiner
Jun 29, 2012·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Fiammetta Cosci
Jan 1, 1985·Behaviour Research and Therapy·B A Thyer, J Himle
Jan 1, 1986·Behaviour Research and Therapy·J MargrafW T Roth
Jul 22, 1998·The Psychiatric Clinics of North America·G R GeffkenD L Evans
Sep 6, 2018·Psychiatry Investigation·Fiammetta Cosci, Giovanni Mansueto
Jan 1, 1987·Acta Psychiatrica Scandinavica. Supplementum·D V Sheehan, S Soto
Jul 1, 1986·The British Journal of Psychiatry : the Journal of Mental Science·D C Taylor
Feb 1, 1986·Psychological Reports·B A Thyer
Feb 1, 1988·Psychological Reports·C A Pollard, G L Cox

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.